January 30, 2018 / 1:19 PM / in 13 minutes BRIEF-First Patient Treated In Mapi Pharma's Phase II Clinical Trial Of GA Depot Reuters Staff 1 Min Read 
Jan 30 (Reuters) - Mapi Pharma Ltd: 
* FIRST PATIENT TREATED IN MAPI PHARMAâ€˜S PHASE II CLINICAL TRIAL OF GA DEPOT FOR PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS) Source text for Eikon: Further company coverage: